United Kingdom

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

12:55am GMT
Change (% chg)

¥32 (+1.52%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

ASKA Pharmaceutical amends consolidated full-year outlook for FY 2016
Monday, 25 Apr 2016 

ASKA Pharmaceutical Co Ltd:Says the company lowered the consolidated full-year outlook for revenue to 43,210 mln yen from 44,000 mln yen for FY ended March 2016.Sees an increased operating profit forecast to 1,160 mln yen from 800 mln yen.Sees an increased ordinary profit forecast to 1,520 mln yen from 1,000 mln yen.Sees an increased net profit forecast to 700 mln yen from 600 mln yen.Sees an increased earnings per share to 25.15 yen from 21.53 yen per share.Comments reduced costs is the main reason for the forecast.  Full Article

ASKA Pharmaceutical signs commercialization contract for treatment of hypertension with Takeda Pharmaceutical
Wednesday, 24 Feb 2016 

ASKA Pharmaceutical Co Ltd:Says signed commercialization contract for a treatment of hypertension with Takeda Pharmaceutical on Feb. 24.Says ASKA Pharmaceutical obtain manufacturing and marketing approval for the treatment of hypertension from the Ministry of Health, Labour and Welfare in February.  Full Article